483
Vesta Pharmaceuticals, Inc.Vesta Pharmaceuticals, Inc. – FDA 483, Feb 9, 2024
Record Details
An FDA inspection of Vesta Pharmaceuticals, Inc. in Indianapolis, IN, a dietary supplement manufacturer, revealed significant deficiencies in quality control and material management. Observations included incomplete batch production records, unverified instrument calibration logs, and improper storage of quarantined and expired materials. These issues indicate a lack of adequate controls over manufacturing processes and product integrity.
View Company Profile
ID · 7b2d68d8-c501-447c-9bd7-7e5a9ae8e89e
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.